Search results
Analysts Expect Breakeven For Mayne Pharma Group Limited (ASX:MYX) Before Long
Simply Wall St. via Yahoo Finance· 2 months agoMayne Pharma Group Limited (ASX:MYX) is possibly approaching a major achievement in its business, so...
Mayne Pharma Group Limited (ASX:MYX) most popular amongst individual investors who own 56% of the...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Mayne Pharma Group Limited (ASX:MYX) should be aware of the most powerful...
Mayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%
Simply Wall St. via Yahoo Finance· 1 year agoThe latest analyst coverage could presage a bad day for Mayne Pharma Group Limited (ASX:MYX), with...
While institutions invested in Mayne Pharma Group Limited (ASX:MYX) benefited from last week's 12%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Mayne Pharma Group's significant retail investors ownership suggests that the key...
Mayne Pharma Group Limited (ASX:MYX) insider upped their holding by 120% earlier this year
Simply Wall St. via Yahoo Finance· 2 years agoInsiders were net buyers of Mayne Pharma Group Limited's (ASX:MYX ) stock during the past year. That...
There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues
Simply Wall St. via Yahoo Finance· 1 year agoMayne Pharma Group Limited's (ASX:MYX) price-to-sales (or "P/S") ratio of 0.9x might make it look...
Retail investors account for 50% of Mayne Pharma Group Limited's (ASX:MYX) ownership, while...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significant control over Mayne Pharma Group by retail investors implies that the...
Does This Valuation Of Mayne Pharma Group Limited (ASX:MYX) Imply Investors Are Overpaying?
Simply Wall St. via Yahoo Finance· 2 years agoHow far off is Mayne Pharma Group Limited (ASX:MYX) from its intrinsic value? Using the most recent...
Mayne Pharma Group Limited (ASX:MYX) Shares Could Be 49% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Mayne Pharma Group's estimated fair value is AU$7.77 based on 2 Stage Free Cash Flow to...
Frank Condella Is The Independent Non-Executive Chairman of Mayne Pharma Group Limited (ASX:MYX) And...
Simply Wall St. via Yahoo Finance· 1 year agoEven if it's not a huge purchase, we think it was good to see that Frank Condella, the Independent...